Nervous System News and Research

Latest Nervous System News and Research

Tailored doses of pre-transplant drug therapy in Glaucomatous patients boosts survival rates to over 90%

Chronic Granulomatous Disease is a rare immune deficiency that seriously compromises organ function and is life-threatening, with 20-30 per cent of patients dying within the first two decades of life.

13 Nov 2013

Using morphine to fight surgical pain may prolong patient's suffering

Using morphine to fight the pain associated with abdominal surgery may paradoxically prolong a patient's suffering, doubling or even tripling the amount of time it takes to recover from the surgical pain, according to researchers at the University of Colorado Boulder.

13 Nov 2013

New view can give scientists better understanding of how antidepressants work in human brain

Research from Oregon Health & Science University's Vollum Institute, published in the current issue of Nature, is giving scientists a never-before-seen view of how nerve cells communicate with each other.

13 Nov 2013

Researchers look to animal models to better understand human brain function, vision loss

Research released today reveals a new model for a genetic eye disease, and shows how animal models - from fruit flies to armadillos and monkeys - can yield valuable information about the human brain. The findings were presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

12 Nov 2013

Researchers identify novel therapeutic approach for most frequent genetic cause of ALS

A team of scientists led by researchers from the University of California, San Diego School of Medicine and Ludwig Institute for Cancer Research have identified a novel therapeutic approach for the most frequent genetic cause of ALS, a disorder of the regions of the brain and spinal cord that control voluntary muscle movement, and frontal temporal degeneration, the second most frequent dementia.

10 Nov 2013

Research findings may lead to new treatments, approaches for controlling multiple sclerosis

Scientists are gaining a new level of understanding of multiple sclerosis that may lead to new treatments and approaches to controlling the chronic disease, according to new research released today at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

10 Nov 2013

Researchers identify chain reaction that triggers regrowth of some damaged nerve cell

Researchers at Washington University School of Medicine in St. Louis have identified a chain reaction that triggers the regrowth of some damaged nerve cell branches, a discovery that one day may help improve treatments for nerve injuries that can cause loss of sensation or paralysis.

8 Nov 2013

Researchers clinically validate new method for predicting Alzheimer's progression

A Columbia University Medical Center-led research team has clinically validated a new method for predicting time to full-time care, nursing home residence, or death for patients with Alzheimer's disease.

8 Nov 2013

Investigators find potential new target for treatment of low-grade gliomas

Investigators at Johns Hopkins have found a known genetic pathway to be active in many difficult-to-treat pediatric brain tumors called low-grade gliomas, potentially offering a new target for the treatment of these cancers.

7 Nov 2013

New study looks at hormone/SNS relationship in women taking hormone contraceptives

After menopause, women's levels of estrogen and progesterone fall. Their formerly lower risk for heart disease equals, even surpasses, men's risk. One possible contributing explanation for the change in risk is that sex hormones affect the sympathetic nervous system, which controls constriction of blood vessels and participates in the fight or flight response.

7 Nov 2013

Study: Speaking a second language may delay onset of three types of dementias

In the largest study on the topic to date, research shows that speaking a second language may delay the onset of three types of dementias. The research is published in the November 6, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Nov 2013

Depomed reports financial results for third quarter 2013

Total revenues were $37.5 million and included recognition of a $5.0 million milestone payment from Mallinckrodt related to the NDA filing of MNK-795. Excluding this milestone and a $10 million upfront payment from Janssen in the third quarter of 2012, total revenues of $32.5 million grew 39% compared to $23.3 million for the third quarter of 2012.

6 Nov 2013

Research: Chronic stress changes gene activity in immune cells before reaching bloodstream

New research shows that chronic stress changes gene activity in immune cells before they reach the bloodstream. With these changes, the cells are primed to fight an infection or trauma that doesn't actually exist, leading to an overabundance of the inflammation that is linked to many health problems.

6 Nov 2013

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Reviva Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the discovery and development of new, safer and highly effective therapies for chronic indications, announced today the successful completion of an End-of-Phase 2 meeting with the Food and Drug Administration for its lead, new investigational antipsychotic drug, RP5063.

5 Nov 2013

Disruption of brain signals contributes to increased pain sensitivity in fibromyalgia patients

New research indicates that a disruption of brain signals for reward and punishment contributes to increased pain sensitivity, known as hyperalgesia, in fibromyalgia patients. Results published in Arthritis & Rheumatism, a journal of the American College of Rheumatology, suggest that this altered brain processing might contribute to widespread pain and lack of response to opioid therapy in patients with fibromyalgia.

5 Nov 2013

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a Prior Approval Supplement for EMBEDA (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII.

4 Nov 2013

Orthopaedic foot and ankle MDs offer tips for diabetic foot care

It's American Diabetes Month, and if you're among the 25 million Americans who have diabetes, you may know that foot care is extremely important. Nervous system impairment, also called neuropathy, is a major complication of diabetes that can cause you to lose feeling in your feet. This means you may not know right away if you have hurt yourself, which could lead to infection.

4 Nov 2013

Nervous System News and Research

Latest Nervous System News and Research

Tailored doses of pre-transplant drug therapy in Glaucomatous patients boosts survival rates to over 90%

Using morphine to fight surgical pain may prolong patient's suffering

New view can give scientists better understanding of how antidepressants work in human brain

Researchers look to animal models to better understand human brain function, vision loss

Researchers identify novel therapeutic approach for most frequent genetic cause of ALS

Research findings may lead to new treatments, approaches for controlling multiple sclerosis

Researchers identify chain reaction that triggers regrowth of some damaged nerve cell

Researchers clinically validate new method for predicting Alzheimer's progression

Investigators find potential new target for treatment of low-grade gliomas

New study looks at hormone/SNS relationship in women taking hormone contraceptives

Study: Speaking a second language may delay onset of three types of dementias

Depomed reports financial results for third quarter 2013

Research: Chronic stress changes gene activity in immune cells before reaching bloodstream

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Disruption of brain signals contributes to increased pain sensitivity in fibromyalgia patients

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Orthopaedic foot and ankle MDs offer tips for diabetic foot care

ACOEM urges employers to respond to the impact of diabetes on worker health and productivity

Alkermes reports 38% of year-over-year revenue growth from key products

e-Therapeutics begins ETS6103 phase IIb trial for major depressive disorder

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Nervous System News and Research

Latest Nervous System News and Research

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in